Literature DB >> 25782623

The application of PADUA scoring system for predicting complications of laparoscopic renal cryoablation.

Junlong Zhuang1, Huibo Lian, Xiaozhi Zhao, Gutian Zhang, Weidong Gan, Xiaogong Li, Hongqian Guo.   

Abstract

PURPOSE: To evaluate the clinical application of preoperative aspects and dimensions used for anatomical (PADUA) scoring system in predicting perioperative surgical outcomes in patients undergoing laparoscopic cryoablation (LCA).
METHODS: A total of 95 consecutive renal tumors treated with LCA between January 2007 and April 2013 were collected. Renal tumors were categorized into low- (6-7), moderate- (8-9), and high-complexity (10-13) groups according to PADUA indices. Demographics, perioperative variables, and complication rates were compared among three groups. Surgical conversion, blood loss >100 mL, tumor fracture, and incomplete ablation were regarded as intraoperative complications (IOCs). All postoperative complications (POCs) were graded using the Clavien-Dindo system. The risk for complications was assessed by univariate and multivariate logistic regression analyses.
RESULTS: The estimated blood loss during LCA was associated with PADUA score. There were 17 (17.9%) IOCs and 20 (21.1%) POCs. Blood loss (>100 mL) was the most common IOC, which occurred in 10 (10.5%) patients. For POC, there were 15 (15.8%) minor complications (Clavien 1-2) and 5 (5.3%) major complications (Clavien 3a). Higher grade of PADUA scores was significantly correlated with the increase incidence of IOC and POC. The PADUA score was an independent predictive factor for POC, and the patients with moderate and high PADUA scores had an over sixfold and 17-fold higher risk compared to the patients with low scores, respectively.
CONCLUSION: Our findings demonstrated, for the first time, the PADUA scoring system is an efficient assessment tool for predicting the perioperative complications in patients undergoing laparoscopic renal cryoablation.

Entities:  

Mesh:

Year:  2015        PMID: 25782623     DOI: 10.1007/s11255-015-0943-y

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  27 in total

1.  Application of a standardized anatomical classification in a Chinese partial nephrectomy series.

Authors:  Wen Kong; Jin Zhang; Baijun Dong; Yonghui Chen; Wei Xue; Dongming Liu; Yiran Huang
Journal:  Int J Urol       Date:  2012-03-29       Impact factor: 3.369

2.  Laparoscopic partial nephrectomy: risk stratification according to patient and tumor characteristics.

Authors:  Stephan Kruck; Aristoteles G Anastasiadis; Ute Walcher; Arnulf Stenzl; Thomas R W Herrmann; Udo Nagele
Journal:  World J Urol       Date:  2012-01-24       Impact factor: 4.226

3.  The RENAL nephrometry score and the PADUA classification for the prediction of perioperative outcomes in patients receiving nephron-sparing surgery: feasible tools to predict intraoperative conversion to nephrectomy.

Authors:  Kazuhiro Kobayashi; Toshihiro Saito; Yasuo Kitamura; Tomohiro Nobushita; Takashi Kawasaki; Noboru Hara; Kota Takahashi
Journal:  Urol Int       Date:  2013-08-23       Impact factor: 2.089

Review 4.  Laparoscopic renal cryoablation.

Authors:  Marc Schiffman; Amiel Moshfegh; Adam Talenfeld; Joseph J Del Pizzo
Journal:  Semin Intervent Radiol       Date:  2014-03       Impact factor: 1.513

5.  Second prize: Recurrence rates after percutaneous and laparoscopic renal cryoablation of small renal masses: does the approach make a difference?

Authors:  Kurt H Strom; Ithaar Derweesh; Sean P Stroup; John B Malcolm; James L'Esperance; Robert W Wake; Robert Gold; Michael Fabrizio; Kerrin Palazzi-Churas; Xiao Gu; Carson Wong
Journal:  J Endourol       Date:  2011-02-28       Impact factor: 2.942

6.  Association of tumor size, location, R.E.N.A.L., PADUA and centrality index score with perioperative outcomes and postoperative renal function.

Authors:  Jason R Bylund; Dustin Gayheart; Tyler Fleming; Ramakrishna Venkatesh; David M Preston; Stephen E Strup; Paul L Crispen
Journal:  J Urol       Date:  2012-09-19       Impact factor: 7.450

7.  Utility of the RENAL nephrometry scoring system in the real world: predicting surgeon operative preference and complication risk.

Authors:  Henry M Rosevear; Paul T Gellhaus; Andrew J Lightfoot; Timothy P Kresowik; Fadi N Joudi; Chad R Tracy
Journal:  BJU Int       Date:  2011-07-20       Impact factor: 5.588

8.  The application of R.E.N.A.L. nephrometry scoring system in predicting the complications after laparoscopic renal radiofrequency ablation.

Authors:  Xiaofeng Chang; Changwei Ji; Xiaozhi Zhao; Fan Zhang; Huibo Lian; Shiwei Zhang; Guangxiang Liu; Gutian Zhang; Weidong Gan; Xiaogong Li; Hongqian Guo
Journal:  J Endourol       Date:  2014-04       Impact factor: 2.942

9.  Laparoscopic cryoablation for clinical stage T1 renal masses: long-term oncologic outcomes at the Medical College of Wisconsin.

Authors:  Scott Johnson; Khanh N Pham; William See; Frank P Begun; Peter Langenstroer
Journal:  Urology       Date:  2014-09       Impact factor: 2.649

10.  Long-term oncologic outcomes of laparoscopic renal cryoablation as primary treatment for small renal masses.

Authors:  Alessandro Larcher; Nicola Fossati; Francesco Mistretta; Giovanni Lughezzani; Giuliana Lista; Paolo Dell'Oglio; Alberto Abrate; Maxine Sun; Pierre Karakiewicz; Nazareno Suardi; Massimo Lazzeri; Francesco Montorsi; Giorgio Guazzoni; Nicolò Buffi
Journal:  Urol Oncol       Date:  2014-10-07       Impact factor: 3.498

View more
  2 in total

1.  Comparisons of percutaneous versus retroperitoneoscopic cryoablation for renal masses.

Authors:  Hui-Ying Liu; Shu-Huei Shen; Lin-Nei Hsu; Po-Hui Chiang
Journal:  Int Urol Nephrol       Date:  2018-07-18       Impact factor: 2.370

2.  The feasibility and safety of modified robot-assisted enucleation for highly complex renal tumors: research on a surgical technique.

Authors:  Zhaoxiang Lu; Jun Zhou; Cheng Yang; Li Zhang; Sheng Tai; Yu Yin; Chaozhao Liang
Journal:  Transl Cancer Res       Date:  2019-06       Impact factor: 1.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.